Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.
about
Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast CancerThe association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasetsMdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatinThe Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERαClaudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data.miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance.SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic markerSMARCE1 is required for the invasive progression of in situ cancersBioinformatics analysis of the prognostic value of Tripartite Motif 28 in breast cancerAn In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter.The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.Exploring functions of long noncoding RNAs across multiple cancers through co-expression networkGlucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT.Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancerMethylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.DDB2 suppresses tumorigenicity by limiting the cancer stem cell population in ovarian cancer.Breast cancer cell adhesome and degradome interact to drive metastasisElafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors.FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth.The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin.WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.NOTCH1 signaling contributes to cell growth, anti-apoptosis and metastasis in salivary adenoid cystic carcinomaOvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement.Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis.Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancersSingle Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis.Survival analysis tools in genomics researchMEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer.PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheresMining CK2 in cancerReverse engineering the neuroblastoma regulatory network uncovers MAX as one of the master regulators of tumor progression.Paradoxical roles of mineral dust induced gene on cell proliferation and migration/invasion.LSD1 overexpression is associated with poor prognosis in basal-like breast cancer, and sensitivity to PARP inhibitionVangl1 and Vangl2: planar cell polarity components with a developing role in cancer.
P2860
Q26785389-D8936949-BC98-499B-AE90-7ABC37BF94EFQ28074028-2A777ABB-64EC-4423-B8DC-EE4EB762AFBCQ28390853-57AE6557-BD3B-4FF4-AEC7-A69E9796B6A9Q28596581-F5088C69-6D35-4BB6-B97E-61F419AFE37CQ30491616-EE01F137-E352-475B-ABF2-8E96FE1BD650Q30583504-BFCDCDED-0A07-4C3C-80A2-A265FC87F9ADQ31136911-F9A6D49F-81CB-4F97-A08B-2FEDFB452625Q33566693-5D13F065-5E26-493D-822A-C3B0BEBE40BFQ33576879-DDF2844F-C72A-4A86-A6AB-51B39162E3A2Q33594853-861B5DE8-9099-44DD-9099-EFD414FC0C66Q33598054-A7FFB3EC-12C9-40DA-B8FB-22BE65120D3BQ33623668-AAFC059F-B535-47B8-BA41-0F6519B90889Q33638726-8C757B34-0A4D-47BA-B9E2-0225F2084A18Q33677918-72D43CE3-C3CA-4227-9FBC-7A9CCC4F584FQ33688593-18F38C1B-7694-44E3-A911-54A6A16365E8Q33688989-573E5F84-5067-443D-BEDA-8DDC8C587097Q33779227-6AB0FD42-4B36-468A-A492-505DA03DA05AQ33787214-436EA290-3022-49D5-BE23-55536D1D56C3Q33827681-3F20EA27-ED00-4220-A50E-0C53CA58632FQ33894314-F82101B2-C855-48C2-B20F-17875A034787Q33914711-2597100A-4CD3-49BE-AB13-C2763FF90394Q33955266-52A0E57E-8ACC-4665-87C3-696D35393C98Q34021043-E12F228F-C0FB-4667-AD72-E28CFC331C0BQ34070330-6CF20DE9-B98B-44A1-A98A-165013D2CDEFQ34120466-140AE57C-1158-4BCE-8CC8-B21F02156927Q34157516-690D10BB-47D2-4E81-ACE6-FB3B8169932BQ34334437-7F6AF314-99F6-491D-B95F-9BDBA842E814Q34447404-456D6720-D5E4-44BF-B08F-3BBA08AF2501Q34475743-CD903F5E-D65D-47E6-8871-191F0E746DA4Q34482866-05B55505-D4FD-4FEE-B8FF-9EF3040C47F3Q34491947-FCCDA4AB-7DDD-450F-8F19-DD86AA332565Q34514528-928A229B-C28B-4AB4-A0B7-EEF72C06E615Q34581807-3F2E9935-36D7-47C2-921D-322A94175C78Q34584317-0C53E5FE-2E00-4529-90E3-14A589398394Q34765897-E880269C-E2D0-40AB-A518-0D3E95588613Q34776090-718493F8-03EC-4DDF-BFC3-4C675BEC2219Q35070297-B7C8A24A-B1AF-47D3-A4DB-3EB1BAF72F31Q35088352-19988644-6EC3-4F86-9709-7F6A60551E74Q35094931-56818F7C-3CE5-4314-B178-54E70530617EQ35096327-E3F834DB-0D18-4198-A437-69E5328FB380
P2860
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Implementing an online tool fo ...... array data from 1287 patients.
@ast
Implementing an online tool fo ...... array data from 1287 patients.
@en
Implementing an online tool fo ...... array data from 1287 patients.
@nl
type
label
Implementing an online tool fo ...... array data from 1287 patients.
@ast
Implementing an online tool fo ...... array data from 1287 patients.
@en
Implementing an online tool fo ...... array data from 1287 patients.
@nl
prefLabel
Implementing an online tool fo ...... array data from 1287 patients.
@ast
Implementing an online tool fo ...... array data from 1287 patients.
@en
Implementing an online tool fo ...... array data from 1287 patients.
@nl
P921
P356
P1476
Implementing an online tool fo ...... array data from 1287 patients.
@en
P2093
András Lánczky
Balázs Gyorffy
P304
P356
10.1530/ERC-11-0329
P577
2012-04-10T00:00:00Z